BWAY News and Press, BrainsWay Ltd. From 09/20/20

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead Tesla (NASDAQ:TSLA) will take top billing this week with its highly-anticipated Battery Day event ...

CRESSKILL, N.J. and JERUSALEM, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako...

CRESSKILL, N.J. and JERUSALEM, Sept. 02, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D.,...

Brainsway (BWAY) appears deeply undervalued, given its strong unit sales, clear path to profitability, and large addressable market. Although Brainsway is not currently the market leader, they have arguably superior technology to competitors and are focused on obtaining clearance to treat a wi...

BrainsWay ( BWAY +21.1% ) has received FDA 510(k) for its deep transcranial magnetic stimulation (Deep TMS) system for use as an aid in short-term smoking cessation in adults. More news on: Brainsway Ltd., Healthcare stocks news, Stocks on the move, Read more ...

Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +67%  on FDA nod for convalescent plasma. More news on: Sonnet BioTherapeutics Holdings, Inc., Liminal BioSciences Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...

Company Intends to Execute a Controlled U.S. Market Release in Early 2021 This is the Company’s third FDA-cleared indication for its Deep TMS System, and is the first FDA clearance in the addiction space for any TMS device CRESSKILL, N.J. and JERUSALEM, Aug. 24, 2020 (GLOBE ...

BrainsWay Ltd. (BWAY) Q2 2020 Earnings Conference Call August 12, 2020 08:30 ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Christopher von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participant...

Brainsway (NASDAQ: BWAY ) : Q2 GAAP EPS of -$0.03 beats by $0.09 . More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

CRESSKILL, N.J. and JERUSALEM, Israel, Aug. 12, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the q...